KRON
Income statement / Annual
Last year (2023), Kronos Bio, Inc.'s total revenue was $6.29 M,
and the percentage change from the previous year is not available.
In 2023, Kronos Bio, Inc.'s net income was -$112.67 M.
See Kronos Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
Operating Revenue |
$6.29 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$4.46 M
|
$4.08 M
|
$4.87 M
|
$605,000.00
|
$160,000.00
|
Gross Profit |
$6.29 M
|
-$4.46 M
|
-$4.08 M
|
-$4.87 M
|
-$605,000.00
|
-$160,000.00
|
Gross Profit Ratio |
1
|
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$86.38 M
|
$93.72 M
|
$112.90 M
|
$43.25 M
|
$13.45 M
|
$5.03 M
|
General & Administrative Expenses |
$41.74 M
|
$43.40 M
|
$38.50 M
|
$14.79 M
|
$3.37 M
|
$1.61 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$41.74 M
|
$43.40 M
|
$38.50 M
|
$14.79 M
|
$3.37 M
|
$1.61 M
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
-$27.41 M
|
$0.00
|
$0.00
|
Operating Expenses |
$128.12 M
|
$137.12 M
|
$151.40 M
|
$58.04 M
|
$16.82 M
|
$6.65 M
|
Cost And Expenses |
$128.12 M
|
$137.12 M
|
$151.40 M
|
$58.04 M
|
$16.82 M
|
$6.65 M
|
Interest Income |
$9.16 M
|
$3.91 M
|
$320,000.00
|
$898,000.00
|
$699,000.00
|
$0.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$3.89 M
|
$0.00
|
$76,000.00
|
Depreciation & Amortization |
$2.14 M
|
$4.46 M
|
$4.08 M
|
$4.87 M
|
$605,000.00
|
$160,000.00
|
EBITDA |
-$119.69 M |
-$128.74 M |
-$147.00 M |
-$79.69 M |
-$15.51 M |
-$6.49 M |
EBITDA Ratio |
-19.04
|
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
-19.38
|
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$9.16 M
|
$3.91 M
|
$320,000.00
|
-$30.40 M
|
$699,000.00
|
-$76,000.00
|
Income Before Tax |
-$112.67 M
|
-$133.20 M
|
-$151.08 M
|
-$88.44 M
|
-$16.12 M
|
-$6.72 M
|
Income Before Tax Ratio |
-17.92
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
-$3.91 M
|
-$1.98 M
|
-$24.36 M
|
-$699,000.00
|
-$70,141.00
|
Net Income |
-$112.67 M
|
-$129.29 M
|
-$149.10 M
|
-$64.09 M
|
-$15.42 M
|
-$6.72 M
|
Net Income Ratio |
-17.92
|
0
|
0
|
0
|
0
|
0
|
EPS |
-1.95 |
-2.3 |
-2.72 |
-1.19 |
-0.29 |
-0.24 |
EPS Diluted |
-1.95 |
-2.3 |
-2.72 |
-1.19 |
-0.29 |
-0.24 |
Weighted Average Shares Out |
$57.74 M
|
$56.20 M
|
$54.75 M
|
$54.07 M
|
$53.04 M
|
$28.45 M
|
Weighted Average Shares Out Diluted |
$57.74 M
|
$56.20 M
|
$54.75 M
|
$54.07 M
|
$53.04 M
|
$28.45 M
|
Link |
|
|
|
|
|
|